HIV and Substance Abuse Clinical Addiction Research and Education (CARE) Program
HIV 和药物滥用临床成瘾研究和教育 (CARE) 计划
基本信息
- 批准号:8252146
- 负责人:
- 金额:$ 36.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-05-01 至 2015-04-30
- 项目状态:已结题
- 来源:
- 关键词:Behavioral SciencesBiometryClinicalClinical ResearchCommunicationCommunitiesDiagnosisDisciplineDiseaseDrug AddictionDrug abuseDrug userEducationEducational CurriculumElementsEpidemiologyFacultyFamily PracticeFellowshipFellowship ProgramFundingGoalsGrantHIVHIV InfectionsHealth ServicesHigh PrevalenceInpatientsInstitutionInstructionInternal MedicineLearningMaster&aposs DegreeMedicalMedical StudentsMedical centerMedicineMentorsMinority GroupsNational Institute of Drug AbuseNeurobiologyNew York CityOutpatientsPharmacologyPhysiciansPopulationPositioning AttributePostdoctoral FellowPreventionPsychiatryQualifyingRequest for ApplicationsResearchResearch MethodologyResearch PersonnelResearch Project GrantsResearch SupportResearch TrainingResidenciesResourcesSiteSocial MedicineStudentsSubstance abuse problemTimeTrainingTraining ProgramsTraining and EducationTranslatingUnited States National Institutes of HealthUniversity HospitalsWorkWritingaddictionbasecareerclinical careclinical practicecollegeevidence baseexperienceimprovedinnovationinterestmedical complicationnoveloperationpopulation healthprogramspublic health relevanceresponseresponsible research conductsubstance abuse treatmentsuccesssymposiumtreatment program
项目摘要
DESCRIPTION (provided by applicant): In response to NIDA's request for applications to support "Research Education Grants in Drug Abuse and Addiction," this application seeks funding to continue, improve, and expand the accomplishments of the Clinical Addiction Research and Education (CARE) Program at the Albert Einstein College of Medicine (Einstein) and its University Hospital, Montefiore Medical Center, including an enhanced focus on HIV and substance abuse. The centerpiece of the CARE Program, which began in 2002, is a post-doctoral fellowship program for physicians interested in careers in drug abuse research and clinical practice. The CARE Program is based in Einstein's Department of Medicine, and draws additional NIDA-funded research mentors from Einstein's Departments of Epidemiology & Population Health and Psychiatry & Behavioral Sciences, as well as from other New York City institutions. In addition to providing clinical research training necessary to prepare physicians for independent careers as HIV and substance abuse researchers, CARE Program faculty collaborate with key educational leaders at Montefiore Medical Center to enhance evidence-based substance abuse training for residents in Internal and Family Medicine, and for Einstein medical students. The CARE Program has been highly successful in its first eight years of operation, and this competitive renewal will build on that success and create new opportunities for research education and training in HIV and substance abuse. The current specific aims are: 1. to continue, improve, and expand the accomplishments of the CARE Fellowship Program, an innovative research-intensive fellowship program for physicians who have completed residencies in Internal Medicine, Family Medicine, or Psychiatry and are seeking careers that combine HIV and substance abuse research and clinical work. 2. To continue, improve, and expand the scope of the CARE Educational Program, an enhanced substance abuse research and clinical training program for residents at Montefiore Medical Center and students at Albert Einstein College of Medicine.
PUBLIC HEALTH RELEVANCE: There is a shortage of well-qualified researchers prepared to conduct clinical, translational, prevention, health services, and treatment research with drug users. At Albert Einstein College of Medicine and its University Hospital, Montefiore Medical Center, we are uniquely positioned to provide such training, given our strong addiction treatment programs, our cadre of outstanding NIDA-funded researchers, and our ability to provide formal training in both clinical research methods and addiction medicine. We are also located in a community with a high prevalence of both HIV and substance abuse related disorders, primarily among racial and ethnic minorities. This application seeks funding to continue a post-doctoral fellowship program for physicians interested in careers in HIV and substance abuse research and clinical practice. We also propose to continue an HIV and substance abuse research and clinical training program for residents and students.
描述(由申请人提供):为了应对NIDA的要求支持“在药物滥用和成瘾方面的研究教育”的要求,该申请寻求资金继续,改善,改善和扩大艾尔伯特·爱因斯坦医学院(Einstein)(Einstein)及其大学医院医学中心的临床成瘾研究与教育计划(CARE)计划(CARE)的成就(CARE),包括HIV和FESTANCES HIV和FENSCANDENCENCENCENCENCENCENCENCENCENCENCERCHANCENCERCENCTION和FIFANCENCERCENCENCENCENCER COMPAINCE。该护理计划的核心始于2002年,是针对对药物滥用研究和临床实践职业感兴趣的医生的博士后研究金计划。该护理计划位于爱因斯坦医学系,并从爱因斯坦流行病学与人口健康与精神病学和行为科学以及其他纽约市的其他机构中吸引了NIDA资助的研究导师。除了提供为艾滋病毒和滥用毒品研究人员的独立职业准备医师准备的临床研究培训外,护理计划还与蒙特菲奥尔医学中心的主要教育领袖合作,以增强内部和家庭医学居民的循证毒品滥用培训,并为爱因斯坦医学生。该护理计划在运营的前八年中取得了非常成功的态度,这种竞争性更新将以这一成功为基础,并为艾滋病毒和滥用药物的研究教育和培训创造新的机会。当前的具体目的是:1。继续,改善和扩大护理奖学金计划的成就,这是一项创新的研究密集型奖学金计划,针对已经完成内科医学,家庭医学或精神病学院居住的医师,并正在寻求将艾滋病毒和药物滥用研究和滥用药物研究和临床工作结合起来的职业。 2。为了继续,改善和扩大护理教育计划的范围,这是为蒙特菲奥尔医学中心的居民以及阿尔伯特·爱因斯坦医学院的学生提供的增强药物滥用研究和临床培训计划。
公共卫生相关性:缺乏合格的研究人员,准备与吸毒者进行临床,转化,预防,卫生服务和治疗研究。鉴于我们的强大成瘾治疗计划,我们的NIDA杰出研究人员的干部以及我们在临床研究方法和成瘾医学方面提供正式培训的能力,在蒙特菲奥尔医学中心的阿尔伯特·爱因斯坦医学院及其大学医院,我们的位置可以提供这种培训。我们还位于一个艾滋病毒和药物滥用相关疾病的社区中,主要是在种族和少数民族中。该申请寻求资金,继续为对艾滋病毒和药物滥用研究和临床实践感兴趣的医生提供博士后奖学金计划。我们还建议继续为居民和学生进行艾滋病毒和药物滥用研究和临床培训计划。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JULIA H. ARNSTEN其他文献
JULIA H. ARNSTEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JULIA H. ARNSTEN', 18)}}的其他基金
Integrated Care for Chronic Pain and Opioid Use Disorder: The IMPOWR Research Center at Montefiore/Einstein (IMPOWR-ME)
慢性疼痛和阿片类药物使用障碍的综合护理:蒙蒂菲奥里/爱因斯坦 IMPOWR 研究中心 (IMPOWR-ME)
- 批准号:
10876693 - 财政年份:2021
- 资助金额:
$ 36.73万 - 项目类别:
Integrated Care for Chronic Pain and Opioid Use Disorder: The IMPOWR Research Center at Montefiore/Einstein (IMPOWR-ME)
慢性疼痛和阿片类药物使用障碍的综合护理:蒙蒂菲奥里/爱因斯坦 IMPOWR 研究中心 (IMPOWR-ME)
- 批准号:
10391075 - 财政年份:2021
- 资助金额:
$ 36.73万 - 项目类别:
Does medical cannabis reduce opioid analgesics in HIV+ and HIV- adults with pain?
医用大麻是否会减少艾滋病毒和艾滋病毒成人疼痛的阿片类镇痛药?
- 批准号:
10177977 - 财政年份:2017
- 资助金额:
$ 36.73万 - 项目类别:
Neurocognitive Effects of Opiate Agonist Treatment in HIV Infected Drug Users
阿片激动剂治疗对 HIV 感染吸毒者的神经认知影响
- 批准号:
8516487 - 财政年份:2012
- 资助金额:
$ 36.73万 - 项目类别:
Neurocognitive Effects of Opiate Agonist Treatment in HIV Infected Drug Users
阿片激动剂治疗对 HIV 感染吸毒者的神经认知影响
- 批准号:
8870318 - 财政年份:2012
- 资助金额:
$ 36.73万 - 项目类别:
Neurocognitive Effects of Opiate Agonist Treatment in HIV Infected Drug Users
阿片激动剂治疗对 HIV 感染吸毒者的神经认知影响
- 批准号:
9185062 - 财政年份:2012
- 资助金额:
$ 36.73万 - 项目类别:
Neurocognitive Effects of Opiate Agonist Treatment in HIV Infected Drug Users
阿片激动剂治疗对 HIV 感染吸毒者的神经认知影响
- 批准号:
8680195 - 财政年份:2012
- 资助金额:
$ 36.73万 - 项目类别:
Neurocognitive Effects of Opiate Agonist Treatment in HIV Infected Drug Users
阿片激动剂治疗对 HIV 感染吸毒者的神经认知影响
- 批准号:
8329872 - 财政年份:2012
- 资助金额:
$ 36.73万 - 项目类别:
Neurocognitive Effects of Buprenorphine Among HIV+ Opioid Users
丁丙诺啡对 HIV 阿片类药物使用者的神经认知影响
- 批准号:
7617365 - 财政年份:2008
- 资助金额:
$ 36.73万 - 项目类别:
Clinical Addiction Research and Education Program
临床成瘾研究和教育计划
- 批准号:
7825368 - 财政年份:2007
- 资助金额:
$ 36.73万 - 项目类别:
相似国自然基金
基于精神分裂症临床队列的免疫组学异常特征及其生物标记物的研究
- 批准号:U22A20304
- 批准年份:2022
- 资助金额:255.00 万元
- 项目类别:联合基金项目
三维磁共振弹性成像评价胰腺癌生物力学特征的实验及临床研究
- 批准号:82071885
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
阿尔兹海默病多模态生物标记物的时序建模及其临床应用
- 批准号:61901120
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
基于群体药代特征的灯台叶总生物碱临床物-效关系研究
- 批准号:81603505
- 批准年份:2016
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
肝脏炎癌恶性转化关键节点的动态网络标志物模型及临床应用研究
- 批准号:91529303
- 批准年份:2015
- 资助金额:250.0 万元
- 项目类别:重大研究计划
相似海外基金
Society of Behavioral Medicine 2023 Annual Meeting & Scientific Sessions
行为医学学会2023年年会
- 批准号:
10681958 - 财政年份:2023
- 资助金额:
$ 36.73万 - 项目类别:
Climate & Health Actionable Research and Translation Center
气候
- 批准号:
10835464 - 财政年份:2023
- 资助金额:
$ 36.73万 - 项目类别:
Michigan Institute for Clinical and Health Research (MICHR)
密歇根临床与健康研究所 (MICHR)
- 批准号:
10621051 - 财政年份:2023
- 资助金额:
$ 36.73万 - 项目类别:
Air Pollution, Multidimensional Behavior, and Neuroimaging in Children with Neurodevelopmental Disorders
空气污染、多维行为和神经发育障碍儿童的神经影像学
- 批准号:
10644622 - 财政年份:2023
- 资助金额:
$ 36.73万 - 项目类别: